Wockhardt planning to raise funds through NCDs

19 Apr 2021 Evaluate

Wockhardt is planning to raise funds through issuance of Non-Convertible Debentures (NCDs) on private placement basis. The meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on April 21, 2021, inter-alia, to consider and approve the proposal for raising of funds.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1298.95 -7.15 (-0.55%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×